Throat Sprays Market - Regional Analysis
North America industry is likely to hold largest revenue share of 30% by 2035, backed by the presence of various major throat sprays manufacturers, a huge number of public awareness campaigns aimed at reducing infectious diseases, and the growing population of elderly people in the region. For instance, the number of adults aged 65 and over had increased by nearly 53 million in 2021, and it is expected to reach 86 million by 2050.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of throat sprays is estimated at USD 562.68 million.
The global throat sprays market size was over USD 543.6 million in 2025 and is anticipated to witness a CAGR of around 3.9%, crossing USD 796.96 million revenue by 2035.
North America is anticipated to secure a 30% share by 2035 in the Throat Sprays Market, supported by the strong presence of leading manufacturers, extensive infectious-disease awareness campaigns, and a steadily expanding elderly population.
Key players in the market include Reckitt Benckiser Group PLC, Procter & Gamble Company, Prestige Consumer Healthcare Inc., Purdue Pharma L.P., Marinomed Biotech AG, Biocidin Botanicals, Melcare Biomedical Pty Ltd, Ursatec GmbH, Puressentiel UK Ltd.
